FDA warns against off-label use of antipsychotic drugs

被引：0
作者：
Huntzinger, A
机构：
来源：
AMERICAN FAMILY PHYSICIAN | 2005年 / 71卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：2205 / 2205
页数：1
相关论文
共 50 条
  • [31] HE WAS LIKE A ZOMBIE: OFF-LABEL PRESCRIPTION OF ANTIPSYCHOTIC DRUGS IN DEMENTIA
    Harding, Rosie
    Peel, Elizabeth
    MEDICAL LAW REVIEW, 2013, 21 (02) : 243 - 277
  • [32] FDA warns of serious hematologic reactions with off-label use of quinine sulfate for night-time leg cramps
    不详
    FORMULARY, 2010, 45 (08) : 264 - 264
  • [33] Regulating off-label drug use - Rethinking the role of the FDA
    Stafford, Randall S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (14) : 1427 - 1429
  • [34] NATIONAL PATTERNS AND TRENDS OF OFF-LABEL USE OF ANTIPSYCHOTIC MEDICATIONS IN THE ELDERLY FOLLOWING FDA BLACK BOX WARNINGS
    Teigland, C.
    Jones, B. T.
    Parente, A. K.
    Wang, R. H.
    Yin, S.
    VALUE IN HEALTH, 2012, 15 (04) : A28 - A29
  • [35] FDA SCRUTINIZES OFF-LABEL PROMOTIONS
    RANDALL, T
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 266 (01): : 11 - 11
  • [36] Off-label use of antipsychotics: Rethinking "off-label"
    Groleger, Urban
    PSYCHIATRIA DANUBINA, 2007, 19 (04) : 350 - 353
  • [37] Off-label use of anticancer drugs in Eastern Switzerland
    Joerger, M.
    ONKOLOGIE, 2013, 36 : 210 - 210
  • [38] Off-Label Use of Drugs and Devices in the Neuroendovascular Suite
    Abdihalim, M. M.
    Hassan, A. E.
    Qureshi, A. I.
    AMERICAN JOURNAL OF NEURORADIOLOGY, 2013, 34 (11) : 2054 - 2063
  • [39] Off-Label Use of Prescription Drugs in Childhood and Adolescence
    Muehlbauer, B.
    Janhsen, K.
    Pichler, J.
    Schoettler, P.
    DEUTSCHES ARZTEBLATT INTERNATIONAL, 2009, 106 (03): : 25 - 31
  • [40] A Clinical Overview of Off-label Use of Gabapentinoid Drugs
    Goodman, Christopher W.
    Brett, Allan S.
    JAMA INTERNAL MEDICINE, 2019, 179 (05) : 695 - 701
12345